FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
After a thorough and comprehensive review of proposals received from suppliers of viral marker testi...
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
Dr. Buff Mair is the new CTS Medical Director and replaces Dr. German Leparc who retired at the begi...
In 2016, the Procleix Panther instrument was introduced by Grifols in support of automated NAT ZIKA ...
Just a reminder that the revised client forms implement today! Don't forget to toss your o...